7 Results for "

ADCYAP1R1

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "ADCYAP1R1" in MCE Product Catalog:

Cat. No.: HY-RS00337
Research Areas:  

Others

ADCYAP1R1 Human Pre-designed siRNA Set A contains three designed siRNAs for ADCYAP1R1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS18214
Research Areas:  

Others

Adcyap1r1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Adcyap1r1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS24691
Research Areas:  

Others

Adcyap1r1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Adcyap1r1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P77120A
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Pituitary adenylate cyclase-activating polypeptide type I receptor; PACAP-R1; ADCYAP1R1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P77120
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: Pituitary adenylate cyclase-activating polypeptide type I receptor; PACAP-R1; ADCYAP1R1
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P89687
Synonyms: Pituitary adenylate cyclase-activating polypeptide type I receptor, PAC1 receptor, PAC1R, PACAP type I receptor, PACAP-R-1, PACAP-R1, ADCYAP1R1

Host:  

Mouse

Application:  

WB, IP, ELISA

Reactivity:  

human

loading...
    loading...
Cat. No.: HY-P992108
CAS No.: 3061442-66-5
Synonyms: RELAX10

Research Areas:  

Cardiovascular Disease

Efadirelaxin alfa (RELAX10) is a highly selective agonist of relaxin/insulin-like family peptide receptor RXFP1. After subcutaneous administration in animal experiments, Efadirelaxin alfa exhibits a significantly prolonged terminal half-life (7 days in mice, 3.75 days in rats), and shows no activity against related receptors such as RXFP2 and RXFP3. Efadirelaxin alfa has significant anti-cardiac hypertrophy and anti-fibrotic effects. Efadirelaxin alfa effectively attenuates and reverses cardiac hypertrophy and collagen deposition by regulating the TGF-β1/Smad2 and AKT/eNOS signaling pathways. Efadirelaxin alfa improves cardiac systolic function without causing fluctuations in blood pressure or heart rate, demonstrating favorable safety. Efadirelaxin alfa is currently mainly used in studies related to heart failure .
loading...
    loading...